Rockville-based MacroGenics reported a third-quarter loss of $20.1 million, or 32 cents per share. The biopharmaceutical company recorded $18.7 million in revenue; its loss adjusted for discontinued operations was 34 cents per share.
Reporting from 1 identified publisher for this event.
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Page 2 of 22219
Same format. Every time.
Continue reading — sign in or create a free account with
